Motion Sickness Relief Tablet
NDC Package 0363-1980-08
Package Information
Motion Sickness Relief (dimenhydrinate) tablets is do not take more than directedto prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activityto prevent or treat motion sickness, see below:adults and children 12 years and over take 1 to 2 tablets every 4-6 hours do not take more than 8 tablets in 24 hours, or as directed by a doctorchildren 6 to under 12 yearsgive 1/2 to 1 tablet every 6-8 hoursdo not give more than 3 tablets in 24 hours, or as directed by a doctorchildren 2 to under 6 yearsgive 1/2 tablet every 6-8 hoursdo not give more than 1½ tablets in 24 hours, or as directed by a doctor. This formulation utilizes a tablet delivery system. Marketed by Walgreen Company, this product is identified by NDC 0363-1980 and is authorized under FDA application M009.
Identification & Billing
- RxCUI: 198603 - dimenhyDRINATE 50 MG Oral Tablet
- RxCUI: 198603 - dimenhydrinate 50 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0363 - Walgreen Company
- 0363-1980 - Motion Sickness Relief
- 0363-1980-08 - 4 BLISTER PACK in 1 CARTON / 6 TABLET in 1 BLISTER PACK
- 0363-1980 - Motion Sickness Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0363-1980-08 identifies a specific commercial package of 4 blister pack in 1 carton / 6 tablet in 1 blister pack of Motion Sickness Relief, a human over the counter drug labeled by Walgreen Company. This tablet is formulated for oral use and contains dimenhydrinate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Walgreen Company on October 22, 2021. The current certification is valid through December 31, 2027.
How is this Walgreen Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00363198008. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.